Baird Financial Group, Inc. - SORRENTO THERAPEUTICS INC ownership

SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 75 filers reported holding SORRENTO THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is 0.47 and the average weighting 0.4%.

Quarter-by-quarter ownership
Baird Financial Group, Inc. ownership history of SORRENTO THERAPEUTICS INC
ValueSharesWeighting
Q3 2016$1,256,000
+6.4%
162,275
-23.0%
0.01%0.0%
Q2 2016$1,180,000
-16.0%
210,777
-19.2%
0.01%
-15.4%
Q1 2016$1,404,000
-36.8%
260,948
+2.2%
0.01%
-40.9%
Q4 2015$2,223,000
-1.9%
255,211
-5.6%
0.02%
-8.3%
Q3 2015$2,267,000
-57.9%
270,225
-11.6%
0.02%
-54.7%
Q2 2015$5,388,000305,7910.05%
Other shareholders
SORRENTO THERAPEUTICS INC shareholders Q2 2015
NameSharesValueWeighting ↓
HUNTINGTON NATIONAL BANK 15,001$1,4100.00%
KLCM Advisors, Inc. 20,000$1,8800.00%
AlphaMark Advisors, LLC 3,135$00.00%
TRUST CO OF VERMONT 204$190.00%
SlateStone Wealth, LLC 30,866$30.00%
Coppell Advisory Solutions LLC 100$890.00%
Highlander Capital Management, LLC 1,200$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
Russell Investments Group, Ltd. 266$250.00%
OGOREK ANTHONY JOSEPH /NY/ /ADV 3,600$00.00%
View complete list of SORRENTO THERAPEUTICS INC shareholders